Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin add-on to Insulin in Japanese T2DM
NCT02002221Phase 4Completed
- Sponsor
- Novartis
- Start
- Dec 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Dec 2013; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02002221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02002221.